Pantomed (Pantoprazole)

Pantoprazole, the active ingredient in Pantomed, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is employed in the management of acid‑related gastrointestinal disorders such as GERD and peptic ulcer disease.

GNH USA supplies Pantomed as a licensed, GDP‑compliant international pharmaceutical product to hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory conformity across global markets through a robust supply chain and dedicated technical support for reliable patient care.

Pantoprazole is used to treat conditions involving excess gastric acid secretion.

- Gastroesophageal reflux disease (GERD): alleviates heartburn and regurgitation by reducing acid exposure in the esophagus. - Erosive esophagitis: promotes healing of inflamed esophageal tissue by maintaining a higher gastric pH. - Peptic ulcer disease: supports ulcer resolution by limiting acid that irritates the gastric lining. - Helicobacter pylori eradication (as part of combination therapy): enhances the effectiveness of antibiotics by creating a less acidic environment.

Pantoprazole may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Headache: mild to moderate pain often occurring early in therapy. - Diarrhea: loose stools that may resolve with continued use. - Nausea: sensation of unease or urge to vomit. - Abdominal pain: discomfort in the stomach region. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmias. - Elevated liver enzymes: potential hepatic irritation. - Interstitial nephritis: inflammation of kidney tissue. - Increased risk of bone fractures: long‑term use may affect calcium absorption.

When prescribing Pantoprazole, several safety considerations should be observed.

- Assess renal function: adjust use in severe renal impairment. - Monitor for infection: be aware of increased risk of C. difficile colitis. - Check magnesium levels: prolonged therapy may cause hypomagnesemia. - Avoid concomitant use with certain antiretrovirals: may reduce their efficacy. - Discontinue before elective surgery: reduce risk of postoperative complications. - Store at room temperature: keep in the original pack, protect from moisture.

Pantoprazole can affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Atazanavir and other protease inhibitors: reduced absorption and therapeutic failure. - Clopidogrel: decreased activation leading to reduced antiplatelet effect. - High‑dose methotrexate: increased toxicity due to impaired renal clearance.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR and bleeding risk. - Diazepam: elevated plasma concentrations may enhance sedation. - Digoxin: reduced absorption may lower efficacy.